BIOMAT Database Logo BIOMAT Database Logo

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). 2003

Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

Leishmania donovani promastigote lines resistant to hexadecylphosphocholine (HePC, miltefosine) at 2.5, 5.0, 10.0, 20.0 and 40.0 microM were developed in vitro by continuous step-wise drug pressure. The 40 microM line was 15 times more resistant to HePC than the wild-type clone and showed cross-resistance to the ether lipid ET-18-OCH3 (edelfosine) but not to the standard anti-leishmanial drugs. Resistance was stable up to 12 weeks in drug-free culture medium. No amplification of specific genes, including the multidrug resistance P-glycoprotein gene, could be detected in the resistant parasites.

UI MeSH Term Description Entries
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D010767 Phosphorylcholine Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. Choline Chloride Dihydrogen Phosphate,Choline Phosphate Chloride,Phosphorylcholine Chloride,Choline Phosphate,Phosphocholine,Chloride, Choline Phosphate,Chloride, Phosphorylcholine,Phosphate Chloride, Choline,Phosphate, Choline
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D016054 DNA, Protozoan Deoxyribonucleic acid that makes up the genetic material of protozoa. Protozoan DNA
D020168 ATP Binding Cassette Transporter, Subfamily B, Member 1 A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE). ATP-Dependent Translocase ABCB1,MDR1 Protein,MDR1B Protein,Multidrug Resistance Protein 1,P-Glycoprotein,P-Glycoprotein 1,ABCB1 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 1,ATP-Binding Cassette, Sub-Family B, Member 1,CD243 Antigen,PGY-1 Protein,1, P-Glycoprotein,ABCB1, ATP-Dependent Translocase,ATP Dependent Translocase ABCB1,Antigen, CD243,P Glycoprotein,P Glycoprotein 1,PGY 1 Protein,Protein, MDR1B,Translocase ABCB1, ATP-Dependent

Related Publications

Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.
April 2007, Antimicrobial agents and chemotherapy,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
April 2007, Antimicrobial agents and chemotherapy,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
November 2009, The Journal of antimicrobial chemotherapy,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
May 2007, Experimental parasitology,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
March 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
March 2004, Antimicrobial agents and chemotherapy,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Characterization of sinefungin-resistant Leishmania donovani promastigotes.
January 1993, Parasitology research,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani.
March 2014, Parasitology research,
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Development and characterization of paromomycin-resistant Leishmania donovani promastigotes.
June 1998, Parasite (Paris, France),
Karin Seifert, and Sangeeta Matu, and F Javier Pérez-Victoria, and Santiago Castanys, and Francisco Gamarro, and Simon L Croft
Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
July 2005, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!